Dr. Shapiro is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
160 E 34th St
# 4
New York, NY 10016Phone+1 212-731-5180
Summary
- Dr. Richard Shapiro is a Professor of Surgery and practicing Surgical Oncologist in New York, NY and is affiliated with NYU Langone Hospitals and serves as Director if Surgical Oncology Operations at the Perlmutter Clinical Cancer Center. He received his medical degree from NYU School of Medicine and has been in practice 29 years. He specializes in malignant melanoma, aggressive cutaneous and soft tissue tumors and breast cancer.
Education & Training
- NYU Grossman School of MedicineResidency, Surgery, 1988 - 1995
- New York University School of MedicineClass of 1988
Certifications & Licensure
- NY State Medical License 1989 - 2025
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
- Join now to see all
Publications & Presentations
PubMed
- 97 citationsInduction of Primary Cutaneous Melanocytic Neoplasms in Urokinase-Type Plasminogen Activator (uPA)-deficient and Wild-Type Mice: Cellular Blue Nevi Invade but Do Not P...Richard L. Shapiro, J. G. Duquette, Daniel F. Roses, Irene Nunes, Matthew N. Harris
Cancer Research. 1996-08-01 - 292 citationsImmune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survivalDusan Bogunovic, David O'Neill, Ilana Belitskaya-Levy, Vladimir Vacic, Yi-Lo Yu
Proceedings of the National Academy of Sciences of the United States of America. 2009-12-01 - 49 citationsIntegrative genomics identifies molecular alterations that challenge the linear model of melanoma progression.Amy E. Rose, Laura Poliseno, Jinhua Wang, Michael Clark, Alexander Pearlman
Cancer Research. 2011-04-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: